Skip to content
All articles
Reference list

The 7 Banned Words That Trigger FDA Warning Letters in Healthcare Marketing (2026 Update)

Seven specific words generate a disproportionate share of FDA warning letters and FTC actions in healthcare marketing. Here is the 2026 list - with the compliant alternative for every word and five adjacent phrases that drag you into the same violation.

10 min readBy RegenCompliance Editorial, FDA/FTC compliance desk

There is no official FDA “banned words” list. What there is, in practice, is a set of specific words that - when tied to a health-condition claim - reliably convert your marketing copy from legal promotion into an unapproved drug representation. After reading a large sample of 2024–2025 warning letters, seven words do most of the damage. These are the ones to get out of your style guide this week.

Each word below maps to a specific regulatory mechanism. That matters, because cleaning up the language isn’t about finding prettier synonyms - it’s about knowing which regulatory theory each word triggers so the rewrite actually survives review.

1. Cure / cures / curing

The single most dangerous word in healthcare marketing. A cure claim is the textbook definition of a disease claim under 21 CFR. It asserts that the product eliminates or permanently resolves a named medical condition - which is exactly what an approved drug does. If you do not have drug approval for the indication, the word “cure” makes your product an unapproved drug.

Non-compliant

Our stem cell therapy cures arthritis.

Compliant alternative

Some patients report reduced joint discomfort after treatment. Individual results vary.

Why: “Cures” + a named disease = unapproved drug representation. The compliant version reports subjective patient experience without making a clinical outcome claim.

Adjacent phrases that ride on “cure”: cured patients, the cure for, cure rate, effective cure. All treated the same by regulators.

2. Heal / heals / healing

The softer-sounding cousin of “cure.” In consumer use, “heal” can mean anything from tissue repair to emotional well-being. In regulatory use, “heal” tied to a condition or body tissue is a disease-efficacy claim. “Heals damaged cartilage” is a cure claim with different phrasing.

Non-compliant

PRP therapy heals damaged tendons and ligaments.

Compliant alternative

PRP therapy may support the body's normal tissue repair processes.

Why: “Heals” asserts a specific biological outcome on damaged tissue. The compliant version describes structure/function support without claiming a repair outcome.

Exception: generic “healing journey,” “post-procedure healing,” and similar uses referring to the normal course of recovery are typically fine when not tied to a specific condition or efficacy claim.

3. Treat / treats (for named conditions)

“Treat” is context-dependent. “Treatment plan” and “treat yourself to a facial” are fine. “Treats fibromyalgia” is a disease claim. The regulatory line lives at the collision between the verb treat and a named medical condition.

Non-compliant

Our IV therapy treats chronic fatigue syndrome.

Compliant alternative

Our IV nutrient formulations are designed to help patients maintain normal energy metabolism.

Why: “Treats” + a named diagnosable condition = indicated use of a drug. The compliant version is structure/function language.

Adjacent phrases: treatment for [condition], effective treatment of [condition], treats the underlying cause of [condition]. Every variant collapses to the same violation.

4. Reverse / reverses / reversal

A special enforcement favorite for anti-aging, metabolic, and regenerative medicine marketing. “Reverses aging,” “reverses hair loss,” “reverses diabetes” all claim a specific pathology is undone by the procedure. That is a drug- level representation.

Non-compliant

Our hormone protocol reverses the signs of aging and restores youthful energy.

Compliant alternative

Our hormone protocol is designed to help patients maintain normal energy levels and overall well-being as part of their broader wellness goals.

Why: “Reverses” aging is both a disease-adjacent claim and an unsubstantiable outcome assertion. The FTC treats it as deceptive, the FDA treats it as unapproved-drug language.

Adjacent phrases: turn back the clock, undo damage, restore youth, rejuvenate (when applied to a body function rather than an aesthetic appearance).

5. Guaranteed / guarantee

Switch regulators for this one. “Guaranteed” is primarily an FTC problem, not an FDA problem. Under Section 5 of the FTC Act, claiming a guaranteed outcome that cannot be substantiated is a deceptive act per se. Healthcare outcomes are essentially never substantiable as guaranteed, because individual biological variation is always present.

Non-compliant

Guaranteed results or your money back.

Compliant alternative

We offer a 30-day satisfaction policy. If you are not satisfied with your initial experience, we will refund the consultation fee.

Why: “Guaranteed results” is an unsubstantiable clinical outcome claim. The compliant version is a specific, bounded, commercial-refund offer - which is legal.

Adjacent phrases: 100% effective, proven results, risk-free, no side effects, zero downtime guaranteed. All hit the same FTC problem.

6. FDA-approved

The most-cited specific phrase in 2024–2025 stem cell and regenerative medicine warning letters. Most clinics using this phrase mean that their facility is FDA-registered as an HCT/P tissue establishment. That is a registration of the facility - not an approval of the product or procedure being sold.

Non-compliant

FDA-approved stem cell therapy for back pain.

Compliant alternative

Performed in an FDA-registered tissue establishment under 21 CFR Part 1271. This procedure is not an FDA-approved drug or device.

Why: Registration is not approval. Implied-approval language is one of the top three citations in warning letters, and the fix is explicit disclosure of what the registration does and does not cover.

Adjacent phrases: FDA-cleared (valid only for specific 510(k) devices, not procedures), FDA-endorsed, FDA-recommended, FDA-compliant procedure (meaningless in regulatory terms but read as implied approval).

7. Proven (without substantiation)

“Proven” is different from the other six because it’s not inherently a disease claim - it’s a substantiation claim. Under FTC guidance, using “proven” obligates you to produce the proof on demand. Most clinics using the word in marketing do not have peer-reviewed clinical substantiation matching the specific claim, which is exactly the gap that makes it deceptive.

Non-compliant

Clinically proven to reduce pain and inflammation.

Compliant alternative

In our clinical experience, many patients report a reduction in discomfort following this protocol. Individual results vary.

Why: “Clinically proven” is a claim about published, substantiable evidence that most clinics cannot document. The compliant version reports internal clinical observation without asserting clinical proof.

If you dohave peer-reviewed clinical substantiation for the exact claim, “proven” is defensible. Keep the citation in a substantiation file next to the claim, not in a separate folder or vendor’s archive.

Five adjacent phrases that drag you into the same violations

Swapping the seven words above for clever synonyms is the most common failed workaround. Regulators are unmoved by paraphrasing. These five adjacent phrases pull clinics into the same enforcement theories:

  • Miracle.“Miracle treatment,” “miracle cure,” “miraculous recovery.” Read as an outsized, unsubstantiated efficacy claim.
  • Breakthrough.Legal in specific FDA designation contexts (“breakthrough therapy designation”), but used loosely in marketing it reads as a disease-efficacy claim.
  • Eliminate / eliminates.Functionally equivalent to “cure” when applied to a condition. “Eliminates wrinkles” is typically fine (aesthetic). “Eliminates chronic pain” is not (medical condition).
  • Immediate / immediately.Combines outcome guarantee and efficacy claim. “Immediate pain relief,” “immediately effective.” Both invite FTC scrutiny on the substantiation theory.
  • Advanced / cutting-edge.Low direct risk, but often used to imply an approved medical status that does not exist. When clinic copy leans on “advanced” as a proxy for “approved,” it gets pulled into the implied-approval theory.
If the only reason a sentence is persuasive is because it contains one of these words, the problem isn’t the word. It’s that the underlying claim was not legally defensible to make in the first place.

How to get these out of your marketing this week

A one-time find-and-replace does not solve this problem. The words drift back in every time a new post is written. The fix is to put the list in front of everyone who writes for your clinic, at the moment they are writing.

1. Add the list to your CMS and ad platforms

Most CMSes support a custom-dictionary or banned-word warning at edit time. Same for Instagram Creator Studio and Meta Ads Manager, which both support custom keyword lists you can use as a writing guard.

2. Scan before publish, not after

A compliance scanner that runs against the copy before publish catches the word while it’s cheap to fix - not after a patient complaint opens a file. Try a free scan.

3. Audit what’s already live

Run a site-wide text search for each of the seven words. Read every instance in context. For each one, either rewrite using the compliant alternative pattern or, if the underlying claim cannot be made compliantly, remove it. Keep a dated audit log.

4. Update the testimonial-solicitation workflow

The second-most-common way these words get into your marketing is through republished patient testimonials. Update your testimonial form to ask patients to describe their experience without using the seven words. Not as censorship - as protection for your clinic.

Built for this exact problem

Scan your clinic's content before regulators do.

RegenCompliance checks every word of your marketing against live FDA and FTC enforcement data - and rewrites violations automatically. A 30-second scan can save a $50,000–$5M regulatory response.

Weekly compliance brief

One email a week. New enforcement actions, rule changes, and tactical fixes. No spam, unsubscribe anytime.

We only send one email per week. No marketing blasts.